FRAAX
Price
$61.15
Change
-$0.11 (-0.18%)
Updated
Dec 3 closing price
Net Assets
4.61B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

FRAAX vs VIGRX

Header iconFRAAX vs VIGRX Comparison
Open Charts FRAAX vs VIGRXBanner chart's image
Franklin Growth Opportunities Adv
Price$61.15
Change-$0.11 (-0.18%)
VolumeN/A
Net Assets4.61B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
FRAAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
FRAAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRAAX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. FRAAX (4.61B). VIGRX pays higher dividends than FRAAX: VIGRX (0.30) vs FRAAX (0.00). FRAAX was incepted earlier than VIGRX: FRAAX (26 years) vs VIGRX (33 years). FRAAX (0.64) is less costly to investors than VIGRX (0.17). FRAAX is a more actively managed with annual turnover of: 27.59 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than FRAAX: VIGRX (3000) vs FRAAX (100000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. FRAAX (-4.51). VIGRX return over 5 years is better than : 99.11 vs. FRAAX (1.78).
FRAAXVIGRXFRAAX / VIGRX
Total Expense Ratio0.640.17376%
Annual Report Gross Expense Ratio0.640.17376%
Fund Existence26 years33 years-
Gain YTD8.55719.76443%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets4.61B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year-4.5118.49-24%
Returns for 3 years40.57110.8237%
Returns for 5 years1.7899.112%
Returns for 10 years71.63349.1321%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT